Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

Active, not recruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

March 21, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Kidney Transplant Rejection
Trial Locations (13)

15261

University of Pittsburgh, Pittsburgh

21201

University of Maryland, Baltimore

37232

Vanderbilt University Medical Center, Nashville

44195

Cleveland Clinic, Cleveland

48202

Henry Ford, Detroit

60611

Northwestern University, Evanston

60612

University of Illinois at Chicago, Chicago

68198

University of Nebraska Medical Center, Omaha

98195

University of Washington, Seattle

Unknown

CHU Grenoble Alpes Health Center, Grenoble

Bologna University, Bologna

Brescia University, Brescia

University Hospital Vall d'Hebron, Barcelona, Barcelona

All Listed Sponsors
lead

Verici Dx

INDUSTRY